Patrice Decker
Papers
1
Total Citations
30
H-Index
1
About
Patrice Decker is a leading researcher in the field of poly(ADP-ribose) polymerase (PARP) biology, with a particular focus on developing therapeutic applications for PARP inhibitors. Her most cited work introduced a groundbreaking nonisotopic ELISA-based screening method that enabled the rapid, reliable, and specific testing of large numbers of potential PARP inhibitor molecules. This methodological innovation, published in 1999 and garnering 30 citations, addressed a critical bottleneck in drug discovery by replacing cumbersome radioactive assays with a high-throughput, accessible alternative. Decker’s contribution directly accelerated the identification of novel PARP inhibitors, which have since become pivotal in cancer therapy, particularly for BRCA-mutated tumors. Her work exemplifies the essential role of assay development in translating basic science into clinical impact. By providing a practical tool for screening inhibitor efficacy, Decker has helped lay the groundwork for the PARP inhibitor class now used in oncology, demonstrating how a single methodological advance can shape an entire therapeutic field. Her research continues to influence both drug discovery and mechanistic studies of PARP activity.
Research Focus
Key Achievements
Top Papers
- 1